Type XXII Collagen Complements Fibrillar Collagens in the Serological Assessment of Tumor Fibrosis and the Outcome in Pancreatic Cancer
Circulating fragments of type III collagen, measured by PRO-C3, has shown promising results as a tumor fibrosis biomarker. However, the fibrotic tumor microenvironment consists of many other collagens with diverse functions and unexplored biomarker potential. One example hereof is type XXII collagen...
Main Authors: | Emilie A. Madsen, Jeppe Thorlacius-Ussing, Neel I. Nissen, Christina Jensen, Inna M. Chen, Julia S. Johansen, Hadi M. H. Diab, Lars N. Jørgensen, Carsten P. Hansen, Morten A. Karsdal, Nicholas Willumsen |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-11-01
|
Series: | Cells |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4409/11/23/3763 |
Similar Items
-
High serum levels of the C-propetide of type V collagen (PRO-C5) are prognostic for short overall survival in patients with pancreatic ductal adenocarcinoma
by: Neel I. Nissen, et al.
Published: (2023-03-01) -
Levels of type XVII collagen (BP180) ectodomain are elevated in circulation from patients with multiple cancer types and is prognostic for patients with metastatic colorectal cancer
by: Marina Crespo-Bravo, et al.
Published: (2023-10-01) -
Preliminary investigation of elevated collagen and blood‐clotting markers as potential noninvasive biomarkers for small cell lung cancer
by: Jeppe Thorlacius‐Ussing, et al.
Published: (2023-10-01) -
Targeting inflammation with collagen
by: Dennis Schwarz, et al.
Published: (2022-05-01) -
Regulation of tumor immunity and immunotherapy by the tumor collagen extracellular matrix
by: Dallas B. Flies, et al.
Published: (2023-08-01)